XJPX
8281
Market cap279mUSD
Jul 10, Last price
1,091.00JPY
1D
-0.46%
1Q
8.02%
Jan 2017
-39.59%
Name
Xebio Holdings Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xebio Holdings Co., Ltd., along with its affiliated companies, operates a diverse sports-related business primarily within Japan, specializing in the retail and distribution of athletic equipment and apparel. The company manages an extensive portfolio of specialized retail formats, including large-scale multi-sport stores like "The Super Sports XEBIO," smaller and medium-sized equipment outlets such as "XEBIO Sports Express" and "NEXAS," and urban-focused "Victoria" brand stores. General sporting goods are also offered under the "Takeda Sports" banner. For niche markets, they operate "Victoria Golf" and "Golf Partner" for golf products, "L-Breath" for outdoor gear, and "next" and "X'tyle" for apparel. Complementary businesses include "X'tyleVision" for sports eyewear and "Xiasis" for health, fitness, and medical products. Beyond its retail presence, Xebio Holdings owns and operates the "Free Blades" ice hockey team, the "Xebio Arena," and "XSPOT" sports community stations. The company's diversified activities further encompass the acquisition and sale of golf merchandise; various corporate services such as marketing, research, consulting, event management, and property administration; alongside international business and research & development initiatives. They are also involved in developing and managing digital sports platforms and overseeing e-commerce operations. Additionally, Xebio provides sales agency services, human resource development, and temporary staffing solutions, in addition to managing a credit card business. Established in 1962, the company is headquartered in Koriyama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||